In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from thailand

Carcinogenesis

Volumn 14, Issue 12, 1993, Pages 2613-2620

  Kirby, G M ^a   Wolf, C R ^a   Neal, G E ^a   Judah, D J ^a   Henderson, C J ^a   Srivatanakul, P ^a   Wild, C P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; AFLATOXIN B1; CUMENE HYDROPEROXIDE; CYTOCHROME P450; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIVER; LIVER METABOLISM; LIVER MICROSOME METABOLISM; LIVER TUMOR; MALE; PRIORITY JOURNAL; THAILAND; XENOBIOTIC METABOLISM;

ADOLESCENT; ADULT; AFLATOXIN B1; AGED; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GLUTATHIONE TRANSFERASE; HUMAN; ISOENZYMES; LIVER NEOPLASMS; MALE; MICROSOMES, LIVER; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; THAILAND;

EID: 0027768734     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/14.12.2613     Document Type: Article

References (52)

1. LSrivantanakul P., Sontipong S., Chotiwan, P. and Parkin D.M. (1988) Liver cancer in Thailand: temporal and geographic variations. J. Gastroenterol. Hepatol, 3, 413-420.
2. Munoz N.M. and Bosch F.X. (1987) Epidemiology of hepatocellular carcinoma. In Okuda.K. and Ishak.K.G. (eds), Neoplasms of the Liver. Springer Verlag, Tokyo, pp. 3-19.
3. Tomatis L., Aitio A., Day N.E., Heseltine E., Kaldor L., Miller A.B., Parkin D.M. and Riboli E. (eds) (1990) Cancer: Causes, Occurrence and Control, IARC Scientific Publication no. 100. International Agency for Research on Cancer, Lyon.
4. Wild C.P., Jansen L.A.M., Cova L. and Montesano R. (1993) Molecular dosimetry of aflatoxin exposure: contribution to understanding tbe multifactorial aetiopathogenesis of primary hepatocelular carcinoma (PHC) with particular reference to hepatitis B virus (HBV). Environ. Health Perspect., 99, 115-122.
5. Srivatanakul P., Parkin D.M., Jiang Y.Z., Khlat M., Kao-Ian U.T., Sontipong S. and Wild C.P. (1991) The role of infection by Opisthorchis viverrini, hepatitis B virus and aflatoxin exposure in the aetiology of liver cancer in Thailand. Cancer, 68, 2411-2417.
6. Neal G.E., Metcalfe S.A., Legg R.F., Judah D.J. and Green J.A. (1981) Mechanism of the resistance to cytotoxicity which precedes aflatoxin B[hepatocarcinogenesis. Carcinogenesis, 2, 457-461.
7. O’Brien K., Moss E., Judah D. and Neal G.E. (1983) Metabolic basis of the species difference to aflatoxin B, induced hepatotoxkity. Biochem Biopftys. Res. Common., 114, 813-821.
8. Gorelick JJ. (1990) Risk assessment for aflatoxin: I. Metabolism of aflatoxin B[by different species. Risk Anal., 10, 539-559.
9. Forrester L.M., Neal G.E., Judah DJ., Glancey MJ. and Wolf C.R. (1990) Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin Bj metabolism in human liver. Proc. Nad. Acad. 5a. USA, 87, 8306-8310.
10. Shimada T. and Guengerich F.P. (1989) Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principle enzyme involved in the bioactivation of aflatoxins in human liver. Proc. NatL Acad Sci. USA, 86, 462-465.
11. Kitada M., Taneda M., Ohta K., Nagashima K, Hahaslri K. and Kamatald T. (1990) Metabolic activation of aflatoxin Bj and 2-amino-3-methylimidazo [4, 5-^jquinoline by human adult and fetal livers. Cancer Res., 50, 2641-2645.
12. Ramsde D H.S., Parkinson A., Ffldy A.C. and Eaton D.L. (1991) Bioactivation of aflatoxin B(by human liver microsomes: role of cytochrome P450 IRA enzymes. Toxicol Appl Pharmacol., 108, 436-447.
13. Aoyama T., Yamano S., Guzelian P.S., Gelboin H.V. and Gonzalez F.J. (1990) Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B,. Proc. Nad. Acad. Sci. USA, 87, 4790-4793.
14. Crespi C.L., Steimel D.T., Aoyama T., Gelboin H.V. and Gonzalez F.J. (1990) Stable expression of human cytochrome P450LA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin Bj. Mol Carcinogenesis, 3, 5-8.
15. Crespi C.L., Penman B.W., Steimel D.T., Gelboin H.V. and Gonzalez F.J. (1991) The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B, and comparison to CYP1A2 and CYP2A3. Carcinogenesis, 12, 355-359.
16. Guengerich F.P., Martin M.V., Beaune P.H., Kramers P., Wolff T. and Waxman D.J. (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polyporphism in oxidative drug metabolism. J. Biol. Chem. 261, 5051-5060.
17. Forrester L.M., Henderson C.J., Glancey M.J., Back D.J., Park B.K., Ball S.E., Kitteringham N.R., McLarcn A.W., Miles J.S., Skett P. and Wolf C.R. (1992) Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem. J., 281, 359-368.
18. Quinn B.A., Crane T.L., Kocal T.E., Bcst S.J., Cameron R.G., Rushmore T.H., Farber E. and Hayes M.A. (1990) Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B[. Toxicol Appl Pharmacol., 105, 351-363.
19. Moss E.J. and Neal G.E. (1985) The metabolism of aflatoxin B(by human liver. Biochem. Pharmacol., 34, 3193-3197.
20. Raney K.D., Meyer D.J., Ketterer B., Harris T.M. and Guengerich F.P. (1992) Glutathione conjugation of aflatoxin B, exo- and endo-epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol., 8, 470-478.
21. Liu Y.H., Taylor J., Linko P., Lucier G.W. and Thompson C.L. (1991) Glutathione S-transferase y in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis, 12, 2269-2275.
22. Board P., Coggan M., Johnston P., Ross V., Suzuki T. and Webb G. (1990) Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol. Ther. 48, 357-369.
23. Idle J.R., Mahgoub A., Sloan T.P., Smith R.L., Mbanefo C.O. and Bababunmi E.A. (1981) Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer. Cancer Lett., 11, 331-338.
24. Lin L., Yang F., Ye Z., Xu E„ Yang C., Zhang C., Wu D., Nebeit D.W. (1991) Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect. Pharmacogenetics, 1, 79-85.
25. Bienvenu T., Rey E., Pons B., D’Athis P. and Olive G.A. (1991) A simple non-invasive procedure for the investigation of cytochrome P-450 DIA dependent enzymes in humans. Int. J. Clin. Pharmacol Ther. Toxicol., 29, 441-445.
26. Groopman J.D., Sabbioni G. and Wild C.P. (1990) Molecular dosimetry of human aflatoxin exposures. In GroopmanJ.D. and Skipper,P.L. (eds), Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations. CRC Press, Boston, MA, pp. 303-324.
27. Hollstein M.C., Wild C.P., Bleicher F., Chutimataewin S., Harris C.C., Srivatanakul P. and Montesano R. (1992) p53 mutations and aflatoxin Bj exposure in hepatocellular carcinoma patients from Thailand. Int. J. Cancer, 53, 1-5.
28. Lowry O.H., Rosebrough N.J., Farr A.L. and Rande U.RJ. (1951) Protein measurement with the Folin phenol reagent. J. Biol Chem., 193, 265-275.
29. Neal G.E., Nielsch U., Judah D.J. and Hulbert P.B. (1987) Conjugation of model substrates or microsomally-activaled aflatoxin B, with reduced glutathione, catalysed by cytosolic glutathione S-transferases in livers of rats, mice and guinea pigs. Biochem. Pharmacol., 36, 4269-4276.
30. Hayes J.D., Judah D.J., McLellan L.I., Kerr L.A., Peacock S.D. and Neal G.E. (1991) Ethoxyquin-induced resistance to aflatoxin B, in the rat is associated with the expression of a novel a-class glutathione S-transferase subunit, Ycj, which possesses high catalytic activity for aflatoxin Bj-8, 9-epoxide. Biochem. J., 279, 385-398.
31. Juvonen R.O., Kaipainen P.K. and Lang M.A. (1985) Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. Eur. J. Biochem., 152, 3-8.
32. Monroe D.H. and Eaton D.L. (1987) Comparative effects of butylaled hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B, in the rat and mouse. Toxicol Appl. Pharmacol., 90, 401-409.
33. Moss E.J., Judah D.J., Przybylslri M. and Neal G.E. (1983) Some mass- spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B,. Biochem J., 210, 227-233.
34. Habig W.H., Pabst M J. and Jacoby W.B. (1974) Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J. Biol Chem., 249, 7130-7139.
35. Paglia D.E. and Valentine W.N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Clin. Med., 70, 158-169.
36. Seidegard J. and Pero R.W. (1985) The hereditary transmission of high glutathione transferase activity towards fra/u-stilbene oxide in human mononuclear leukocytes. Hum Genet., 69, 66-68.
37. Lewis A.D., Hickson I.D., Robson C.N., Harris A.L., Hayes J.D., Griffiths S.A., Manson M.M., Hall JV.E., Moss J.E. and Wolf C.R. (1988) Amplification and increased expression of a class glutathione S-transferase- encoding genes associated with resistance to nitrogen mustards. Proc. Nad. Acad Sci. USA, 85, 8511-8515.
38. Hunt C.M., Westerkam W.R. and Stave G.M. (1992) Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol., 44, 275-283.
39. Raney K.D., Shimada T., Kim D.-H., Groopman J.D., Harris T.M. and Guengerich JLP. (1992) Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Qj as a detoxication product of aflatoxin B). Chem Res. Toxicol., 5, 202-210.
40. Ramsdell H.S. and Eaton D.L. (1990) Species susceptibility to aflatoxin B! carcinogenesis: comparative ldnetks of microsomal biotransfonnatioii. Cancer Res., 80, 615-620.
41. Groopmanr I D., Wild C.P., Hasler J., Chen J., Wogan G.N. and Kensler T.W. (1992) Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-yV7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ. Heahh Perspea., 99, 107-113.
42. Kensler T.W., Egner P.A., Dolan P.M., Groopnan J.D. and Roebuck B.D. (1987) Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-l, 2-dithiol-3-thione (Oltipraz) and related l, 2-dithiol-3-ones. Cancer Res., 47, 4271-4277.
43. Ramsdell H.S. and Eaton D.L. (1990) Mouse liver glutathione S-transferase isoenzyme activity toward aflatoxin B,-8, 9-epoxide and betEo{a]pyrene-7, 8-dihydrodiol-9, 10-epoxide. TaxicoL AppL Pharmacol., 105, 216-225.
44. Mandel H.G., Manson M.M., Judah D.J., Simpson J.L., Gteea J.A., Forrester L.M., Wolf C.R. and Neal G.E. (1987) Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B, hepatocarcinogenesis in the rat. Cancer Res., 47, 5218-5223.
45. Simula T.P., Glancey M.J. and Wolf C.R. (1993) Human glutathione S- transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: studies with halogenated compounds, aromatic amines and aflatoxin Bt. Carcinogenesis, 14, 1371-1376.
46. Morel F., Fardel O., Meyer D.J., Langouet S., Gilmore K.S., Meunier B., Tu C.P.D., Kensler T.W., Ketterer B. and Guillouzo A. (1993) Preferential increase of glutathione 5-transferase class a transcripts in cultured human hepatocytes by phcnobaibital, 3-methylcholanthrene and dithiolethiones. Cancer Res., 83, 231-234.
47. Wild C.P., Fortuin M., Donato F., Whittle H.C., Hall A.J., Wolf C.R. and Montesano R. (1993) Aflatoxin, liver enzymes and hepatitis B virus infection in Gambian children. Cancer Epimiol. BioL Prev., 2, 1-7.
48. El Mouehli M., Didolkar M.S., Elias E.G., Guengerich F.P. and Kauffman F.C. (1987) Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. Cancer Res., 47, 460-466.
49. Soma Y., Satoh K. and Sato K. (1986) Purification and subunit-structural and immunological characterization of five glutathione S-transferases in human liver, and the acidic form as a hepatic tumor marker. Biochim. Biophys. Acta, 869, 247-258.
50. Ross R.K., Yuan J.-M., Yu M.C., Wogan G.N., Qian G.-S., Tu J.-T., Groopman J.D., Gao Y.-T. and Henderson B.E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
51. Hall A.J. and Wild C.P. (1992) Aflatoxin biomarkers. Letter to the Editor. Lancet, 339, 1413-1414.
52. Ross R.K., Yu M.C., Henderson B.E., Yuan J.-M., Qian G.-S., Tu J.-T., Gao Y.-T., Wogan G.N. and Groopman J.D. (1992) Aflatoxin biomarkers. Letter to the Editor. Lancet, 340, 119.